Is "Product Hopping" Anti-Competitive or Fair Game?: A Look at the Second and Third Circuit Divisions in Actavis PLC and Mylan Pharmaceuticals
North Carolina Central University Science & Intellectual Property Law Review
Part of the Antitrust and Trade Regulation Commons